Skip to main content

Table 1 Study characteristics

From: Effects of the timing of tourniquet release in cemented total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials

Study

Publication year

Group size

Total size

Lost to follow-up

Mean age (years)

BMI (kg/m2)

Drainage

Cuff pressure

Anticoagulation

The duration of tourniquet (minutes)

  

Early

Late

 

Early

Late

Early

Late

Early

Late

   

Early

Late

Kvederas et al. [3]

2013

14

15

36

2

3

68.2

67.3

32.0

31.1

Y

N.A.

Heparin

37

60

Leão et al. [24]

2013

20

20

40

0

0

65.3

65.4

N.A.

N.A.

Y

350

N.A.

N.A.

N.A.

Dutton et al. [23]

2012

28

20

48

0

0

N.A.

N.A.

N.A.

N.A.

Y/N

N.A.

Enoxaparin

N.A.

N.A.

Yavarikia et al. [5]

2010

33

22

55

0

0

64

68

N.A.

NA

Y

220–275

Heparin

63

78

Steffin et al. [14]

2009

17

20

37

0

0

66.9

65.6

33.4

32.5

Y

N.A.

Enoxaparin

N.A.

N.A.

Hernandez et al. [16]

2008

21

22

43

0

0

75.9

76

N.A.

N.A.

Y

N.A.

N.A.

N.A.

N.A.

Hersekli et al. [15]

2004

36

40

76

0

0

65

68

N.A.

N.A.

Y

350–400

Coumadin

79

83

Schuh et al. [9]

2003

35

35

70

0

0

N.A.

N.A.

N.A.

N.A.

Y

N.A.

Enoxaparin

72

102

Widman et al. [8]

1999

46

39

81

0

0

N.A.

N.A.

N.A.

NA

Y

300–350

Heparin

N.A.

N.A.

Barwell et al. [2]

1997

44

44

88

0

0

N.A.

N.A.

N.A.

NA

Y

Twicea

N.A.

N.A.

N.A.

Newman et al. [22]

1979

38

42

80

0

0

N.A.

N.A.

N.A.

NA

N.A.

N.A.

Heparin

N.A.

N.A.

  1. N.A. not available.
  2. aTwice the systolic blood pressure.